Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.

Switzerland’s top officials are expected to determine whether big commitments to the U.S. can help secure relief from Trump’s ...

Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...